Latest News

Latest News

News from the World Hepatitis Alliance

Joining expert committees to promote harm reduction

31 Jan 2015 Bridie Taylor

Harm reduction policies are proven to save lives. Globally, as many as 67% of People Who Inject Drugs (PWIDs) have hepatitis C and an additional 8.4...

Promoting screening among high risk communities with new multi-lingual tool

31 Jan 2015 Bridie Taylor

In Europe, migrant populations are disproportionally affected by hepatitis B and C. Crucial to reducing the burden is improving screening among these...

Supporting the development of national action plans in South America

31 Jan 2015 Bridie Taylor

Government commitment to comprehensive national action plans is key to addressing the burden of viral hepatitis. To support the development of...

Exploring new treatment developments and innovative ways to finance healthcare

31 Jan 2015 Bridie Taylor

New therapeutic developments are revolutionising the way hepatitis is treated. But with a global lack of funding, how can these pioneering new drugs...


News from infohep

Swiss opioid substitution therapy programme reports strong progress towards hepatitis C elimination

14 Apr 2021 Keith Alcorn
Direct-acting antiviral treatment cured almost everyone treated for hepatitis C in a large cohort of people receiving opioid substitution therapy,...

Reinfection after hepatitis C cure predicted by sexually transmitted infections

7 Apr 2021 Keith Alcorn
Screening for sexually transmitted infections in people coinfected with HIV and hepatitis C during or shortly after completing direct-acting...

Outreach to homeless in England achieved large-scale testing for hepatitis C during the COVID-19 lockdown

25 Mar 2021 Keith Alcorn
Outreach to homeless people in England housed in temporary accommodation during the COVID-19 pandemic led to over 1200 to be tested for hepatitis C,...

12 good practices that should be part of the hepatitis C standard of care

25 Mar 2021 Keith Alcorn
Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with...

Pancreatic and colorectal cancer risk raised in people with hepatitis C

16 Mar 2021 Keith Alcorn
Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer...

People with HIV and hepatitis B should have ongoing monitoring for liver cancer

15 Mar 2021 Liz Highleyman
People with HIV and hepatitis B co-infection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment and should...

COVID-19 slows viral hepatitis elimination, global survey finds

22 Feb 2021 Keith Alcorn
COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in...

Hepatitis C does not raise the risk of death from COVID-19

19 Feb 2021 Keith Alcorn
People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to...

Hepatitis C treatment reduces stroke and heart attack risk

18 Feb 2021 Keith Alcorn
Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the...

Hepatitis C declining among drug users in UK

11 Feb 2021 Keith Alcorn
The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since...